Characteristic histologic features of human hepatocellular carcinoma with mutant p53 protein

World Journal of Surgery

Volumn 20, Issue 2, 1996, Pages 215-220

  Okuda, Toyokazu ^a   Hirohashi, Kazuhiro ^a   Kinoshita, Hiroaki ^a   Wakasa, Kenichi ^b   Sakurai, Masami ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAB 1801; MUTANT PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER GRADING; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN LOCALIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; COLORING AGENTS; FEMALE; FIXATIVES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; PORTAL VEIN; THROMBOSIS; TISSUE EMBEDDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030043651     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900033     Document Type: Conference Paper

References (35)

1. Okuda, K.: Hepatocellular carcinoma: recent progress. Hepatology 15:948, 1988
2. Makino, R., Hayashi, K., Sugimura, T.: c-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature 310:697, 1984
3. Alcorn, J.A., Feitelberg, S.P., Brenner, D.A.: Transient induction of c-jun during hepatic regeneration. Hepatology 11:909, 1990
4. Hunter, T.: Cooperation between oncogenes. Cell 64:249, 1991
5. Marshall, C.J.: Tumor suppressor genes. Cell 64:313, 1991
6. Fearon, E.R., Vogelstein, B.: A genetic model for colorectal tumorigenesis. Cell 61:759, 1990
7. Chang, F., Syrjänen, S., Kurvinen, K., Syrjänen, K.: The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am. J. Gastroenterol. 88:174, 1993
8. Finlay, C.A., Hinds, P.W., Levine, A.J.: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083, 1989
9. Ginsberg, D., Mechta, F., Yaniv, M., Oren, M.: Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. U.S.A. 88:9979, 1991
10. Hupp, T.R., Meek, D.W., Midgley, C.A., Lane, D.P.: Regulation of the specific DNA binding function of p53. Cell 71:875, 1992
11. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., Tlsty, T.D.: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923, 1992
12. Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., Oren, M.: Specific interaction between the p53 cellular rumour antigen and major heat shock proteins. Nature 320:182, 1986
13. Hainaut, P., Milner, J.: Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and a role in the regulation of p53 conformation. EMBO J. 11:3513, 1992
14. Gannon, J.V., Greaves, R., Iggo, R., Lane, D.P.: Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J. 9:1595, 1990
15. Kihana, T., Tsuda, H., Teshima, S., Okada, S., Matsuura, S., Hirohashi, S.: High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn. J. Cancer Res. 83:978, 1992
16. Challen, C., Lunec, J., Warren, W., Collier, J., Bassendine, M.F.: Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16:1362, 1992
17. Saegusa, M., Takano, Y., Kishimoto, H., Wakabayashi, G., Nohga, K., Okudaira, M.: Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas: an enhanced immunohistochemical approach. J. Cancer Res. Clin. Oncol. 119:737, 1993
18. Hsu, H-C., Tseng, H-J., Lai, P-L., Lee, P-H., Peng, S-Y.: Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res. 53:4691, 1993
19. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., Hirohashi, S.: Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res. 52:3674, 1992
20. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., et al.: Genetic changes and histopathological grades in human hepatocellular carcinomas. Jpn. J. Cancer Res. 84:893, 1993
21. Nishida, N., Fukuda, Y., Kokuryu, H., et al.: Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res. 53:368, 1993
22. Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., Sugimachi, K.: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res. 53:2884, 1993
23. Murakami, Y., Hayashi, K., Hirohashi, S., Sekiya, T.: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 51:5520, 1991
24. Kanai, T., Hirohashi, S., Upton, M.P., et al.: Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 60:810, 1987
25. Sakamoto, M., Hirohashi, S., Shimosato, Y.: Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum. Pathol. 22:172, 1991
26. Tsuda, H., Hirohashi, S., Shimosato, Y., Terada, M., Hasegawa, H.: Clonal origin of atypical adenomatous hyperplasia of the liver and Clonal identity with hepatocellular carcinoma. Gastroenterology 95: 1664, 1988
27. Kanai, T., Hirohashi, S., Upton, M.P., et al.: Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 60:810, 1987
28. Sakamoto, M., Hirohashi, S., Tsuda, H., Shimosato, Y., Makuuchi, M., Hosoda, Y.: Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am. J. Surg. Pathol. 13:1064, 1989
29. Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., Maeda, S.: p53 Gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res. 54:231, 1994
30. Yamada, Y., Yoshida, T., Hayashi, K., et al.: p53 Gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res. 51:5800, 1991
31. Tahara, E., Kuniyasu, H., Nakayama, H., Yasui, W., Yokozaki, H.: Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers. Can To Kagaku Ryoho 20:326, 1993
32. Pohl, J., Goldfinger, N., Radler-Pohl, A., Rotter, V., Schirrmacher, V.: p53 Increases experimental metastatic capacity of murine carcinoma cells. Mol. Cell. Biol. 8:2078, 1988
33. Kondo, Y., Wada, K.: Intrahepatic metastasis of hepatocellular carcinoma: a histopathologic study. Hum. Pathol. 22:125, 1991
34. Nagasue, N., Yukaya, H., Chang, Y-C., et al.: Assessment of pattern and treatment of intrahepatic recurrence after resection of hepato-cellular carcinoma. Surg. Gynecol. Obstet. 171:211, 1990
35. Nagasue, N., Uchida, M., Makino, Y., et al.: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105:488, 1993